Literature DB >> 32843454

High-grade B-cell lymphoma with MYC and BCL6 rearrangements presenting as a cervical mass.

Philippos Apolinario Costa1, Brandon S Needelman2, Youley Tjendra3, James E Hoffman4.   

Abstract

Lymphoid malignancies represent 0. 008% of all cervical tumours. While uncommon, lymphoid malignancies of the gynaecological tract require careful diagnosis and classification to ensure appropriate treatment. We present a case of a 54-year-old woman with HIV who presented with urinary and faecal incontinence for 2 weeks, associated with the feeling of a mass in her vagina. A smooth flesh-coloured pelvic mass was seen on physical examination, and a transvaginal biopsy revealed infiltration of atypical lymphoid cells with fluorescence in situ hybridisation positive for MYC and BCL6, and negative for IGH/BCL2. Bone marrow and cerebral spinal fluid analysis also showed involvement by atypical lymphocytes. She was diagnosed with stage IV high-grade B-cells lymphoma (HGBLs) with MYC and BCL6 rearrangements. She was given R-CODOX-M plus IVAC with no evidence of disease at 4-month follow-up. To our knowledge, this is the first literature report of a HGBL with MYC and BCL6 rearrangement presenting as a cervical mass. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cervical cancer; gynaecological cancer; haematology (incl blood transfusion); malignant disease and immunosuppression

Mesh:

Substances:

Year:  2020        PMID: 32843454      PMCID: PMC7449310          DOI: 10.1136/bcr-2020-235451

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?

Authors:  Deborah A Thomas; Susan O'Brien; Stefan Faderl; John T Manning; Jorge Romaguera; Luis Fayad; Fredrick Hagemeister; Jeffrey Medeiros; Jorge Cortes; Hagop Kantarjian
Journal:  Curr Hematol Malig Rep       Date:  2011-03       Impact factor: 3.952

Review 2.  Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements.

Authors:  Pierre Sesques; Nathalie A Johnson
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

3.  Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literature.

Authors:  Noelle V Frey; Jakub Svoboda; Charalambos Andreadis; Donald E Tsai; Stephen J Schuster; Rebecca Elstrom; Stephen C Rubin; Sunita D Nasta
Journal:  Leuk Lymphoma       Date:  2006-09

Review 4.  Gynecological Lymphoma: A Case Series and Review of the Literature.

Authors:  Einat Slonimsky; Jacob Korach; Tamar Perri; Tima Davidson; Sara Apter; Yael Inbar
Journal:  J Comput Assist Tomogr       Date:  2018 May/Jun       Impact factor: 1.826

Review 5.  Double-hit lymphoma: So what?

Authors:  Andrew Davies
Journal:  Hematol Oncol       Date:  2019-06       Impact factor: 5.271

6.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

7.  The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.

Authors:  R M Braziel; D A Arber; M L Slovak; M L Gulley; C Spier; C Kjeldsberg; J Unger; T P Miller; R Tubbs; C Leith; R I Fisher; T M Grogan
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

8.  Malignant lymphoma of the cervix uteri: histology and ultrastructure.

Authors:  I Carr; A S Hill; B Hancock; F F Neal
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

9.  Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.

Authors:  Asima Kaleem Ahmad; Pei Hui; Babak Litkouhi; Masoud Azodi; Thomas Rutherford; Shirley McCarthy; Mina LuQing Xu; Peter E Schwartz; Elena Ratner
Journal:  Int J Gynecol Cancer       Date:  2014-09       Impact factor: 3.437

10.  Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.

Authors:  A Lacasce; O Howard; S Lib; D Fisher; A Weng; D Neuberg; M Shipp
Journal:  Leuk Lymphoma       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.